The effects of rosiglitazone on lipid and glucose metabolism, insulin resistance and inflammatory factors in type 2 diabetic patients

( views:125, downloads:0 )
Author:
HUANG Bin()
LUO Lin()
HAN Wen-qun()
()
()
()
Journal Title:
CHINESE JOURNAL OF DIABETES
Issue:
Volume 14, Issue 01, 2006
DOI:
Key Word:

Abstract: Compared with the 39 cases with T2DM treated by SU+metformin,the 43 T2DM patients treated by SU+metformin+rosiglitazone for 12 weeks had the improved glycemic and lipid profile controls,increased insulin sensitivity,and decreased CRP level(all P<0.05 or <0.01).

  • [1]朱禧星,潘长玉,李光伟,等.磺酰脲类药物合用马来酸罗格列酮治疗2型糖尿病的有效性和完全性观察.中华内分泌代谢杂志,2003,19:附录3-1~3-6.
  • [2]Wolffrenbuttel BHR,Gomist R,Squatrito S,et al.Addition of low-dose rosiglitazone to sulfonylurea therapy improves glycaemic control in type 2 diabetic patients.Diabetic Med,2000,17:40-47.
  • [3]Pradhan A D,Manson J E,Nader R,et al.C-reactive protein,interleukin-6,and risk of developing type 2 diabetes mellitus.JAMA,2001,286:327-334.
  • [4]Pickup JC,Crook MA.Is type Ⅱ diabetes mellitus a disease of innate immune system? Diabetologia,1998,41:1241-1248.
  • [5]Grigsby RJ,Dobrowsky RT.Inhibition of ceramide productionreverses TNF-induced insulin resistance.Biochem Biophys Res Commun,2001,287:1121 1124.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn